Assure (IONM) Stock Forecast, Price Target & Predictions

IONM Stock Forecast

Assure stock forecast is as follows: an average price target of $2.20K (represents a 4313625.49% upside from IONM’s last price of $0.05) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.

IONM Price Target

The average price target for Assure (IONM) is $2.20K based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $2.20K to $2.20K. This represents a potential 4313625.49% upside from IONM's last price of $0.05.

IONM Analyst Ratings

Buy

According to 1 Wall Street analysts, Assure's rating consensus is 'Buy'. The analyst rating breakdown for IONM stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Assure Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Jun 14, 2022	Scott Henry	Roth Capital	$2.20K	$884.00	148.87%	4313625.49%

The latest Assure stock forecast, released on Jun 14, 2022 by Scott Henry from Roth Capital, set a price target of $2.20K, which represents a 148.87% increase from the stock price at the time of the forecast ($884.00), and a 4313625.49% increase from IONM last price ($0.05).

Assure Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	-
Avg Price Target	-	-	-
Last Closing Price	$0.05	$0.05	$0.05
Upside/Downside	-100.00%	-100.00%	-100.00%

In the current month, the average price target of Assure stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Assure's last price of $0.05. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Jun 14, 2022	Roth Capital		Buy	Initialise

Assure's last stock rating was published by Roth Capital on Jun 14, 2022. The company Initialise its IONM rating from "null" to "Buy".

Assure Financial Forecast

Assure Revenue Forecast

	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jul 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20
Revenue	-	-	-	-	-	$48.00K	$1.54M	$3.55M	$-1.57M	$6.20M	-	$4.70M	$9.66M	$8.55M	$6.22M	$4.76M	$5.96M	$3.96M	$-10.74M
Avg Forecast	$10.00M	$8.00M	$6.90M	$6.00M	$8.50M	$6.00M	$3.90M	$4.43M	$7.35M	$5.82M	$6.75M	$8.90M	$6.80M	$6.70M	$5.00M	$5.50M	$5.00M	$3.00M	$4.00M
High Forecast	$10.00M	$8.00M	$6.90M	$6.00M	$13.84M	$6.00M	$3.90M	$4.43M	$7.35M	$5.82M	$6.75M	$8.90M	$6.80M	$6.70M	$5.00M	$5.50M	$5.00M	$3.00M	$4.00M
Low Forecast	$10.00M	$8.00M	$6.90M	$6.00M	$3.16M	$6.00M	$3.90M	$4.43M	$7.35M	$5.82M	$6.75M	$8.90M	$6.80M	$6.70M	$5.00M	$5.50M	$5.00M	$3.00M	$4.00M
# Analysts	1	1	1	1	1	1	1	1	1	-	-	-	-	-	-	-	-	-	-
Surprise %	-	-	-	-	-	0.01%	0.40%	0.80%	-0.21%	1.07%	-	0.53%	1.42%	1.28%	1.24%	0.87%	1.19%	1.32%	-2.68%

Assure's average Quarter revenue forecast for Dec 23 based on 1 analysts is $8.50M, with a low forecast of $3.16M, and a high forecast of $13.84M. IONM's average Quarter revenue forecast represents a 17608.33% increase compared to the company's last Quarter revenue of $48.00K (Sep 23).

Assure EBITDA Forecast

	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jul 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20
# Analysts	1	1	1	1	1	1	1	1	1	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	$-5.45M	$-6.13M	$-3.08M	$-11.05M	$-1.05M	-	$-3.80M	$335.00K	$806.00K	$-1.18M	$-1.35M	$-1.22M	$-575.00K	$-13.65M
Avg Forecast	$-5.77M	$-4.61M	$-3.98M	$-3.46M	$-4.90M	$-3.46M	$-2.25M	$-2.55M	$-4.24M	$-3.35M	$-3.89M	$-879.04K	$-2.08M	$-2.05M	$-1.53M	$-1.68M	$-1.53M	$-916.12K	$-1.22M
High Forecast	$-5.77M	$-4.61M	$-3.98M	$-3.46M	$-1.82M	$-3.46M	$-2.25M	$-2.55M	$-4.24M	$-3.35M	$-3.89M	$-703.23K	$-2.08M	$-2.05M	$-1.53M	$-1.68M	$-1.53M	$-916.12K	$-1.22M
Low Forecast	$-5.77M	$-4.61M	$-3.98M	$-3.46M	$-7.98M	$-3.46M	$-2.25M	$-2.55M	$-4.24M	$-3.35M	$-3.89M	$-1.05M	$-2.08M	$-2.05M	$-1.53M	$-1.68M	$-1.53M	$-916.12K	$-1.22M
Surprise %	-	-	-	-	-	1.58%	2.73%	1.20%	2.61%	0.31%	-	4.32%	-0.16%	-0.39%	0.77%	0.81%	0.80%	0.63%	11.17%

0 analysts predict IONM's average Quarter EBITDA for Mar 22 to be $-879.04K, with a high of $-703.23K and a low of $-1.05M. This is -362.40% lower than Assure's previous annual EBITDA (Dec 21) of $335.00K.

Assure Net Income Forecast

	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jul 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20
# Analysts	1	1	1	1	1	1	1	1	1	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	$-7.44M	$-5.26M	$-4.31M	$-21.49M	$-1.43M	-	$-2.46M	$-309.00K	$91.00K	$-1.31M	$-1.23M	$-499.00K	$-977.00K	$-12.98M
Avg Forecast	$25.96M	$-9.73M	$-25.96M	$-37.32M	$6.49M	$-24.34M	$-90.86M	$-404.53M	$-194.69M	$-40.86B	$-11.90M	$-1.01M	$-48.35M	$-6.04M	$6.11M	$6.04M	$12.09M	$-12.09M	-
High Forecast	$25.96M	$-9.73M	$-25.96M	$-37.32M	$6.49M	$-24.34M	$-90.86M	$-404.53M	$-194.69M	$-40.86B	$-11.90M	$-811.47K	$-48.35M	$-6.04M	$6.11M	$6.04M	$12.09M	$-12.09M	-
Low Forecast	$25.96M	$-9.73M	$-25.96M	$-37.32M	$6.49M	$-24.34M	$-90.86M	$-404.53M	$-194.69M	$-40.86B	$-11.90M	$-1.22M	$-48.35M	$-6.04M	$6.11M	$6.04M	$12.09M	$-12.09M	-
Surprise %	-	-	-	-	-	0.31%	0.06%	0.01%	0.11%	0.00%	-	2.42%	0.01%	-0.02%	-0.21%	-0.20%	-0.04%	0.08%	-

Assure's average Quarter net income forecast for Dec 21 is $-48.35M, with a range of $-48.35M to $-48.35M. IONM's average Quarter net income forecast represents a -53228.41% decrease compared to the company's last Quarter net income of $91.00K (Sep 21).

Assure SG&A Forecast

	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jul 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20
# Analysts	1	1	1	1	1	1	1	1	1	-	-	-	-	-	-	-	-	-	-
SG&A	-	-	-	-	-	$3.54M	$3.42M	$3.34M	$4.14M	$3.54M	-	$4.49M	$4.86M	$3.43M	$4.13M	$3.47M	$4.15M	$2.31M	$1.87M
Avg Forecast	$117.32M	$93.86M	$80.95M	$70.39M	$99.72M	$70.39M	$45.75M	$51.96M	$86.20M	$68.25M	$79.19M	$1.85M	$8.21M	$8.09M	$6.04M	$6.64M	$6.04M	$3.62M	$4.83M
High Forecast	$117.32M	$93.86M	$80.95M	$70.39M	$162.37M	$70.39M	$45.75M	$51.96M	$86.20M	$68.25M	$79.19M	$2.22M	$8.21M	$8.09M	$6.04M	$6.64M	$6.04M	$3.62M	$4.83M
Low Forecast	$117.32M	$93.86M	$80.95M	$70.39M	$37.08M	$70.39M	$45.75M	$51.96M	$86.20M	$68.25M	$79.19M	$1.48M	$8.21M	$8.09M	$6.04M	$6.64M	$6.04M	$3.62M	$4.83M
Surprise %	-	-	-	-	-	0.05%	0.07%	0.06%	0.05%	0.05%	-	2.42%	0.59%	0.42%	0.68%	0.52%	0.69%	0.64%	0.39%

Assure's average Quarter SG&A projection for Dec 23 is $99.72M, based on 1 Wall Street analysts, with a range of $37.08M to $162.37M. The forecast indicates a 2713.80% rise compared to IONM last annual SG&A of $3.54M (Sep 23).

Assure EPS Forecast

	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jul 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20
# Analysts	1	1	1	1	1	1	1	1	1	-	-	-	-	-	-	-	-	-	-
EPS	-	-	-	-	-	$-0.00	$-0.00	$-4.09	$-28.60	$-1.88	-	$-3.81	$-0.50	$0.20	$-2.20	$-2.20	$-1.00	$-2.80	$-38.00
Avg Forecast	$2.88	$-1.08	$-2.88	$-4.14	$0.72	$-2.70	$-10.08	$-44.88	$-21.60	$-81.60	$-1.70	$-0.40	$-8.00	$-1.00	$1.01	$1.00	$2.00	$-2.00	-
High Forecast	$2.88	$-1.08	$-2.88	$-4.14	$0.72	$-2.70	$-10.08	$-44.88	$-21.60	$-81.60	$-1.70	$-0.40	$-8.00	$-1.00	$1.01	$1.00	$2.00	$-2.00	-
Low Forecast	$2.88	$-1.08	$-2.88	$-4.14	$0.72	$-2.70	$-10.08	$-44.88	$-21.60	$-81.60	$-1.70	$-0.40	$-8.00	$-1.00	$1.01	$1.00	$2.00	$-2.00	-
Surprise %	-	-	-	-	-	0.00%	0.00%	0.09%	1.32%	0.02%	-	9.53%	0.06%	-0.20%	-2.18%	-2.20%	-0.50%	1.40%	-

According to 0 Wall Street analysts, Assure's projected average Quarter EPS for Dec 21 is $-8.00, with a low estimate of $-8.00 and a high estimate of $-8.00. This represents a -4100.00% decrease compared to IONM previous annual EPS of $0.20 (Sep 21).

Assure Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
TOI	Oncology Institute	$0.19	$8.00	4110.53%	Buy
ACHC	Acadia Healthcare Company	$39.64	$81.50	105.60%	Buy
AMED	Amedisys	$85.37	$143.38	67.95%	Hold
AGL	agilon health	$2.00	$3.17	58.50%	Buy
HCA	HCA Healthcare	$307.78	$423.20	37.50%	Buy
PNTG	Pennant Group	$29.21	$34.67	18.69%	Buy
AIRS	AirSculpt	$6.29	$6.67	6.04%	Hold
AVAH	Aveanna Healthcare	$4.78	$5.00	4.60%	Buy
SNDA	Sonida Senior Living	$24.50	$13.00	-46.94%	Sell

IONM Forecast FAQ

Is Assure a good buy?

Yes, according to 1 Wall Street analysts, Assure (IONM) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of IONM's total ratings.

What is IONM's price target?

Assure (IONM) average price target is $2.2K with a range of $2.2K to $2.2K, implying a 4313625.49% from its last price of $0.051. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Assure stock go up soon?

According to Wall Street analysts' prediction for IONM stock, the company can go up by 4313625.49% (from the last price of $0.051 to the average price target of $2.2K), up by 4313625.49% based on the highest stock price target, and up by 4313625.49% based on the lowest stock price target.

Can Assure stock reach $0?

IONM's average twelve months analyst stock price target of $2.2K supports the claim that Assure can reach $0 in the near future.

What are Assure's analysts' financial forecasts?

Assure's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $22.83M (high $28.17M, low $17.49M), average EBITDA is $-13.166M (high $-10.086M, low $-16.245M), average net income is $-513M (high $-513M, low $-513M), average SG&A $267.83M (high $330.48M, low $205.19M), and average EPS is $-56.94 (high $-56.94, low $-56.94). IONM's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $30.9M (high $30.9M, low $30.9M), average EBITDA is $-17.82M (high $-17.82M, low $-17.82M), average net income is $-47.051M (high $-47.051M, low $-47.051M), average SG&A $362.52M (high $362.52M, low $362.52M), and average EPS is $-5.22 (high $-5.22, low $-5.22).

Did the IONM's actual financial results beat the analysts' financial forecasts?

Based on Assure's last annual report (Dec 2022), the company's revenue was $10.98M, which missed the average analysts forecast of $28.81M by -61.91%. Apple's EBITDA was $-22.236M, beating the average prediction of $-12.364M by 79.84%. The company's net income was $-30.112M, missing the average estimation of $-41.069B by -99.93%. Apple's SG&A was $16.01M, missing the average forecast of $235.49M by -93.20%. Lastly, the company's EPS was $-40.06, missing the average prediction of $-105 by -61.96%. In terms of the last quarterly report (Sep 2023), Assure's revenue was $48K, missing the average analysts' forecast of $6M by -99.20%. The company's EBITDA was $-5.452M, beating the average prediction of $-3.46M by 57.56%. Assure's net income was $-7.439M, missing the average estimation of $-24.337M by -69.43%. The company's SG&A was $3.54M, missing the average forecast of $70.39M by -94.97%. Lastly, the company's EPS was $-0.0012, missing the average prediction of $-2.7 by -99.96%